<DOC>
	<DOCNO>NCT00043212</DOCNO>
	<brief_summary>The purpose clinical research study assess safety efficacy investigational therapy call DCVax ( TM ) -Prostate .</brief_summary>
	<brief_title>Study Drug DCVax ( tm ) -Prostate Treat Prostate Cancer When Hormone Therapy Longer Effective .</brief_title>
	<detailed_description>Patients hormone refractory prostate cancer eligible rise PSA three few metastatic lesion . The experimental therapy use patient 's white blood cell `` teach '' cell recognize `` flag '' prostate cancer cell . This may help immune system destroy prostate cancer cell . Side effect report Phase I/II trial include skin reaction redness , pain &amp; swell injection site , short-lived headache , fever &amp; fatigue . Full detail available informed consent .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Inclusion Criteria Hormone refractory prostate cancer ( HRPC ) &amp; # 8211 ; progressive disease despite androgen deprivation serum testosterone &lt; 50ng/dL ; progression define either : 1 . Rising PSA 6 month least 50 % increase 1st 3rd measurement , 3rd measurement &gt; 2.0 ng/ml ; 2 . Progression metastatic lesion bone scan , 3 . Progression lymph node metastasis CT scan . Zubrod ECOG performance status 01 . Three few bone metastases bone scan minimal symptom . No lymph node lesion great 3.0 cm long diameter . Adequate hematological , hepatic renal function . Exclusion Criteria History active malignancy . Prior chemotherapy , radiation therapy , immunosuppressive investigational therapy metastatic disease previous 12 month . Strong opioids , immunosuppressive , megestrol acetate estrogenic hormone ( e.g. , Saw Palmetto , PCSPES ) within 1 month prior enrollment . Brain , liver , lung metastasis ; uncontrolled heart , liver , lung , renal disease serious illness . Prior splenectomy . History severe asthma , anaphylaxis , serious adverse reaction vaccine antigen include skin test . History moderate severe low limb lymphedema , recent sign deep venous thrombosis ( DVT ) thromboembolic disease , impend stroke . History immunodeficiency autoimmune disease ; positive HIV , HbsAg antiHCV . Impending untreated spinal cord compression urinary outlet obstruction . Any medication might affect immune function . ( Exceptions : Nonprescription dose NSAIDS ; acetaminophen aspirin ; low dos antihistamine therapy ; normal range dose vitamin ; H2 blocker ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>oncology</keyword>
	<keyword>urology</keyword>
	<keyword>hormone refractory prostate cancer</keyword>
</DOC>